The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7.
- DOI
- 10.1016/j.apsb.2026.06.053
- Published
- 2026 Sep
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.06.053,
title = {The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7.},
author = {Meng Y and Hu S and Lin F and Zhu Y and Xiong Y and Sun Y and Lin Q and Lu M and Yi N and Xiao T and Wang H and Sheng J and Xu Y and Li C and Zhao C and Lu H and Sachinidis A and Li L and Peng L},
year = {2026},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2026.06.053},
url = {https://doi.org/10.1016/j.apsb.2026.06.053}
}RIS
TY - JOUR TI - The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7. AU - Meng Y AU - Hu S AU - Lin F AU - Zhu Y AU - Xiong Y AU - Sun Y AU - Lin Q AU - Lu M AU - Yi N AU - Xiao T AU - Wang H AU - Sheng J AU - Xu Y AU - Li C AU - Zhao C AU - Lu H AU - Sachinidis A AU - Li L AU - Peng L PY - 2026 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2026.06.053 UR - https://doi.org/10.1016/j.apsb.2026.06.053 ER -
APA
Y, M., S, H., F, L., Y, Z., Y, X., Y, S., Q, L., M, L., N, Y., T, X., H, W., J, S., Y, X., C, L., C, Z., H, L., A, S., L, L., & L, P. (2026). The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.06.053
Source records
- pubmed · retrieved 2026-09-25T02:12:06.009Z